Viking Global Opportunities Portfolio GP LLC, 10% Owner at Urovant Sciences Ltd. (UROV), bought 13,838 shares at $8.58 ($115K) on 2019-06-11, disclosed to the SEC on 2019-06-11.
Scheduled purchase ($115k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.97 | 6,649 | $53K | 46.2% |
| 2 | $8.58 | 7,189 | $62K | 53.8% |
| Total | $8.29 avg | 13,838 | $115K | 100% |